Patent foramen ovale : story closed?
- The optimal treatment strategy for secondary prevention in patients with cryptogenic stroke and patent foramen ovale (PFO) has been a matter of controversy for decades. After three randomized trials failed to show a benefit of closure with an excess of complications in the interventional arm, two large recent trials suggest a benefit with regard of preventing further ischemic strokes. With this discrepancy in results it is important to discuss recent trials in detail and evolve an informed clinical approach for daily practice.
Download full text files
Additional Services
| Author: | Martin KöhrmannORCiDGND, Peter Dieter SchellingerORCiDGND, Georgios TsivgoulisORCiDGND, Thorsten SteinerORCiDGND |
|---|---|
| URN: | urn:nbn:de:hebis:30:3-490821 |
| DOI: | https://doi.org/10.5853/jos.2018.03097 |
| ISSN: | 2287-6391 |
| ISSN: | 2287-6405 |
| Pubmed Id: | https://pubmed.ncbi.nlm.nih.gov/30732440 |
| Parent Title (English): | Journal of stroke |
| Publisher: | Korean Stroke Society |
| Place of publication: | Seoul |
| Document Type: | Article |
| Language: | English |
| Year of Completion: | 2019 |
| Date of first Publication: | 2019/01/31 |
| Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
| Release Date: | 2019/02/19 |
| Tag: | Foramen ovale; Intracranial embolism; Stroke; patent |
| Volume: | 21 |
| Issue: | 1 |
| Page Number: | 8 |
| First Page: | 23 |
| Last Page: | 30 |
| Note: | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| HeBIS-PPN: | 446488569 |
| Institutes: | Medizin / Medizin |
| Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
| Sammlungen: | Universitätspublikationen |
| Licence (English): |  Creative Commons - Namensnennung-Nicht kommerziell 4.0 |
